New research suggests that early use of hormone replacement therapy (HRT) may significantly reduce risks of breast cancer, stroke, and myocardial infarction in women during menopause.
- A recent analysis indicates that women using hormone replacement therapy (HRT) for at least 10 years before their final period may have a lower risk of breast cancer.
- The study highlights the potential benefits of estrogen in HRT, suggesting it may also reduce risks of stroke and myocardial infarction for women during menopause.
- Researchers emphasize the importance of these findings for advancing discussions on womens health and preventive measures related to menopause, breast cancer, and heart health.
Why It Matters
This research offers hope for improving womens health outcomes by potentially lowering the risks associated with menopause, particularly breast cancer and cardiovascular diseases. It underscores the need for further investigation into hormone therapies and their preventive roles.